China Money Network
Login
Join

Hillhouse Capital, Decheng Capital Lead $60M Series B Round In US DNA Sequencing Platform Developer Omniome

  • August 2, 2018 — 10:20 CST

This Data Is Locked!

This area is available only to Subscribers.

Hillhouse Capital and Chinese healthcare-focused investment firm Decheng Capital have led a US$60 million series B found in San Diego-based DNA sequencing platform developer Omniome,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: